Oversizing Increases Pacemaker Implantation Rate After Sutureless Minimally Invasive Aortic Valve Replacement.


Journal

Innovations (Philadelphia, Pa.)
ISSN: 1559-0879
Titre abrégé: Innovations (Phila)
Pays: United States
ID NLM: 101257528

Informations de publication

Date de publication:
Historique:
pubmed: 8 8 2020
medline: 5 8 2021
entrez: 8 8 2020
Statut: ppublish

Résumé

Cardiac conduction system disturbances potentially leading to permanent pacemaker implantation are significant postoperative complications after aortic valve replacement. The aim of this study was to assess the impact of sutureless prosthetic valve oversizing on permanent pacemaker implantation rate. This multicenter retrospective study included 306 patients who underwent minimally invasive aortic valve replacement with the Perceval sutureless valve. Oversizing was determined by the implanted valve size indexed to body surface area. Data were analyzed with a multivariable logistic regression model. This study confirmed excellent postoperative results for minimally invasive aortic valve replacement with right anterior minithoracotomy approach and rapid deployment sutureless valves. Mortality rate was 1%. Eighteen (5.9%) patients received a new permanent pacemaker. Multivariable logistic regression model ( Oversizing of sutureless prosthetic aortic valves is a risk factor for postoperative permanent pacemaker implantation. Proper sizing of Perceval is important to avoid complications and ensure optimal valve performance.

Identifiants

pubmed: 32758051
doi: 10.1177/1556984520938897
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

449-455

Auteurs

Borut Geršak (B)

37663 School of Medicine, University of Ljubljana, Slovenia.
Nisteri Medicine and Research, Phoenix, AZ, USA.

Mattia Glauber (M)

46769 Istituto Clinico Sant'Ambrogio - Clinical & Research Hospital IRCCS - Gruppo Ospedaliero San Donato, Milano, Italy.

Denis Bouchard (D)

25465 Montreal Heart Institute, Montreal, Canada.

Jure Jug (J)

37663 School of Medicine, University of Ljubljana, Slovenia.

Marco Solinas (M)

366975 Ospedale del Cuore-Fondazione Monasterio, Massa-Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH